Servier Symphogen A/S: Financial statements 2016
CVR: 10013267
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
Servier Symphogen A/S (CVR 10013267) has filed annual accounts for 2016. In 2016, the company reported revenue of DKK 214,235,000 and a net result of DKK -414,940,000 compared with DKK -360,147,000 the year before. That is an increase of 341.5% compared with the year before. The profit margin was -193.7%. Equity in the 2016 report amounted to DKK -90,430,000.
- Revenue
- DKK 214,235,000
- Profit/Loss
- DKK -414,940,000
- Equity
- DKK -90,430,000
- Total Assets
- DKK 1,124,036,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | 214.2 mio. | - | -414.9 mio. | -90.4 mio. | - |
| 2015 | 48.5 mio. | - | -360.1 mio. | 232.1 mio. | - |
| 2014 | 98.7 mio. | - | -122.6 mio. | 221.9 mio. | - |
Official annual report
Find more companies like Servier Symphogen A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
As of September 28, 2016, Martin Olin has joined the board of directors of Servier Symphogen A/S.
As of September 1, 2016, Martin Olin is registered as adm. dir. of Servier Symphogen A/S.
As of August 31, 2016, Kirsten Aarup Drejer has stepped down as director of Servier Symphogen A/S.
Servier Symphogen A/S has published its annual report for 2015. Revenue came to DKK 48,526,000, and the net result was DKK -360,147,000.
As of May 10, 2016, Jess Christoffer Søderberg has joined the board of directors of Servier Symphogen A/S.
As of May 10, 2016, Jeffrey Howard Buchalter has joined the board of directors of Servier Symphogen A/S.
As of May 10, 2016, Morten Aleksandr Engel has left the board of directors of Servier Symphogen A/S.
As of May 10, 2016, Annika Carin Margareta Espander Jansson has left the board of directors of Servier Symphogen A/S.
About Servier Symphogen A/S
Servier Symphogen A/S is a Danish company of the type Aktieselskab based in Ballerup, founded in 2000. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named SYMPHOGEN A/S and THERAMAB ApS. The management consists of Christophe Jacques Alain Henri Thurieau. The board consists of Claude Philippe Bertrand (chair), Benoit Alain Antoine Chéron, Christophe Jacques Alain Henri Thurieau and Pascal Lemaire. The company is owned by Les Laboratoires Servier. The company has 197 employees (2026). In 2025, the company reported revenue of DKK 593,829,000 and a net result of DKK 39,133,000 compared with DKK 37,336,000 the year before. Equity in the 2025 report amounted to DKK 162,857,000.